FOR IMMEDIATE RELEASE
David W. Moskowitz MD
ST. LOUIS—August 25, 2009—GenoMed® (OTC Pink Sheets GMED.PK), the Public Health Company™, announced today that it has entered into discussions with the Department of Health of the Philippines to eliminate 95% of kidney failure from that country.
This follows on GenoMed’s earlier memorandum of understanding with LaSalTech, a call center in Bacolod, Republic of the Philippines (RP). GenoMed will teach LaSalTech physicians its “recipe” and they, in turn, will recommend it to the 20 million adults with high blood pressure in the RP. An electronic record will be created for each patient, and GenoMed will supervise the operation from its St. Louis headquarters.
GenoMed and LaSalTech are also in discussions with a chain of retail pharmacies which would serve as the point of contact with the country’s 20 million hypertensive patients.
Said Dr. Moskowitz, GenoMed’s CEO, “We’re delighted that the Department of Health of the Philippines is interested in supporting us. Their involvement is crucial.”
Dr. Moskowitz continued, “If we succeed at a state-of-the-art, prevention-based healthcare solution for even the poorest Filipino, we will be able to export it to other countries, especially the US. President Obama has called for just such a solution. Unfortunately, Medicare has had no interest whatsoever in cutting 10% of its budget, or $35 billion a year.”
Dr. Moskowitz ended by saying, “The Philippine government, on the other hand, simply can’t afford to dialyze 20,000 new patients each year, and is committed to prevention. Our partner, LaSalTech, and Brother Rolando Dizon, its Chairman, helped make this happen. This is a great day for GenoMed’s shareholders. We finally get a chance to show our stuff in a nation of 90 million.”
About LaSalTech (www.lasaltech.com)
LaSalTech was the first Internet service provider in Bacolod, a city of 750,000 in Negros Occidental, the sugar-growing province of the Philippine Islands. Several years ago, LaSalTech entered the growing business of Call Centers. Brother Rolando Dizon, its Chairman, has been a trusted advisor to Philippine Presidents. He helped Cory Aquino overthrow former President Ferdinand Marcos.
About GenoMed (www.genomed.com)
GenoMed is a Next Generation Disease Management company that aims to deliver the best patient outcomes at the lowest possible cost. GenoMed wants to prove that it can arrest diabetes, hypertension, and emphysema even in a developing country with scant resources like the Philippines. GenoMed intends to be the global healthcare provider of choice, especially for America’s 50 million uninsured.
Safe Harbor Statement
This press release contains forward looking statements, including those statements pertaining to GenoMed, Inc.’s (the Company’s) finances and treatments. The words or phrases “ought to,” “should,” “could,” “may,” or similar expressions are intended to identify “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from those projected in the forward looking statements as a result of a number of risks and uncertainties, including but not limited to our research and development being subject to scientific, economic, regulatory, governmental, and technological factors. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. Unless otherwise required by applicable law, we specifically disclaim any obligation to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.